Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.28+0.08 (+6.67%)
Close on Nov 12, 2026Market cap $11.53MP/E –Yield –
Lisata Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Lisata Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -16427.0%. For fiscal 2025 it was -10711.2%, against -2240.9% the year before. The highest annual figure on record is -27.0% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -10711.2% | −8470.3 |
| FY2024 | Dec 31, 2024 | -2240.9% | −2157.3 |
| FY2016 | Dec 31, 2016 | -83.6% | +422.7 |
| FY2015 | Dec 31, 2015 | -506.3% | −184.4 |
| FY2014 | Dec 31, 2014 | -321.9% | −70.9 |
| FY2013 | Dec 31, 2013 | -250.9% | −38.9 |
| FY2012 | Dec 31, 2012 | -212.0% | +126.3 |
| FY2011 | Dec 31, 2011 | -338.4% | −311.3 |
| FY2010 | Dec 31, 2010 | -27.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -3079.0% | −3025.0 |
| Q2 FY2025 | Jun 30, 2025 | -6954.3% | −6892.8 |
| Q4 FY2024 | Dec 31, 2024 | -494.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -81.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -54.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -61.5% | – |
See a number that looks wrong?